| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Clinical Neuroimmunology Unit (Department of Neurology) (Drs. Tintoré, Río, Nos, Sastre-Garriga, Pericot, Comabella, and Montalban) and Magnetic Resonance Unit (Department of Radiology) (Drs. Rovira, Grivé, and Sánchez), Hospital Universitari Vall d’Hebron, Barcelona, Spain.
Address correspondence and reprint requests to Dr. Mar Tintoré, Unitat de Neuroimmunologia Clínica (UNIC), Escola d’Infermeria 2a planta, Hospital Universitari Vall d’Hebron, Pg Vall d’Hebron 119-129, 08035 Barcelona, Spain; e-mail: tintore{at}hg.vhebron.es
Background: Recently developed diagnostic criteria for MS (McDonald criteria) indicate that in patients with a single demyelinating episode (clinically isolated syndromes [CIS]), evidence for dissemination in space and time, essential for diagnosis, may be provided by MRI.
Objective: To assess the usefulness of these new criteria in patients with CIS suggestive of MS. Methods: A total of 139 patients with CIS followed for a median of 3 years underwent brain MRI within 3 months of their first attack and again 12 months later. The number and location of lesions at baseline, the development of new lesions at follow-up, and the results of CSF examination (which, if positive, requires fewer MR abnormalities for diagnosis) were analyzed. The new McDonald criteria (incorporating MRI) were compared to the existing Poser diagnostic criteria and their accuracy was evaluated.
Results: At 12 months, 11% had clinically definite MS according to the Poser criteria compared to 37% with the McDonald criteria. Eighty percent of patients fulfilling these new criteria developed a second clinical episode within a mean follow-up of 49 months. The new criteria showed a sensitivity of 74%, specificity of 86%, and accuracy of 80% in predicting conversion to clinically definite MS.
Conclusion: One year after symptom onset, more than three times as many patients with CIS were diagnosed with MS using new diagnostic criteria incorporating MRI results compared to older criteria. However, the proposed MRI criteria require further prospective studies to optimize sensitivity and specificity.
This article has been cited by other articles:
|
|
 |
|
  C Tur, M Tintore, A Rovira, C Nos, J Rio, N Tellez, I Galan, H Perkal, M Comabella, J Sastre-Garriga, et al. Very early scans for demonstrating dissemination in time in multiple sclerosis Multiple Sclerosis, June 1, 2008; 14(5): 631 - 635. [Abstract] [PDF]
|
|
|
|
|
|
M. Simo, P. Barsi, and Z. Aranyi Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria Multiple Sclerosis, May 1, 2008; 14(4): 472 - 478. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Q. Hintzen and G. Giovannoni CSF analysis in suspected MS: Do bands aid? Neurology, March 25, 2008; 70(13_Part_2): 1059 - 1060. [Full Text] [PDF]
|
|
|
|
|
|
C. H. Polman Early diagnosis of multiple sclerosis-still a challenge? Multiple Sclerosis, January 1, 2008; 14(1): 2 - 3. [PDF]
|
|
|
|
|
|
V. Tomassini, L. De Giglio, M. Reindl, P. Russo, I. Pestalozza, P. Pantano, T. Berger, and C. Pozzilli Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS Multiple Sclerosis, November 1, 2007; 13(9): 1086 - 1094. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Calabrese, N. De Stefano, M. Atzori, V. Bernardi, I. Mattisi, L. Barachino, A. Morra, L. Rinaldi, C. Romualdi, P. Perini, et al. Detection of Cortical Inflammatory Lesions by Double Inversion Recovery Magnetic Resonance Imaging in Patients With Multiple Sclerosis Arch Neurol, October 1, 2007; 64(10): 1416 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Banwell, M. Shroff, J. M. Ness, D. Jeffery, S. Schwid, B. Weinstock-Guttman, and for the International Pediatric MS Study Group MRI features of pediatric multiple sclerosis Neurology, April 17, 2007; 68(16_suppl_2): S46 - S53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Pelayo, M. Tintore, X. Montalban, A. Rovira, C. Espejo, M. Reindl, and T. Berger Antimyelin Antibodies with No Progression to Multiple Sclerosis N. Engl. J. Med., January 25, 2007; 356(4): 426 - 428. [Full Text] [PDF]
|
|
|
|
 |
|
 M.P. Wattjes, G.G. Lutterbey, J. Gieseke, F. Traber, L. Klotz, S. Schmidt, and H.H. Schild Double Inversion Recovery Brain Imaging at 3T: Diagnostic Value in the Detection of Multiple Sclerosis Lesions AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 54 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kappos, C. H. Polman, M. S. Freedman, G. Edan, H. P. Hartung, D. H. Miller, X. Montalban, F. Barkhof, L. Bauer, P. Jakobs, et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes Neurology, October 10, 2006; 67(7): 1242 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tintore, A. Rovira, J. Rio, C. Nos, E. Grive, N. Tellez, R. Pelayo, M. Comabella, J. Sastre-Garriga, and X. Montalban Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology, September 26, 2006; 67(6): 968 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.P. Wattjes, M. Harzheim, C.K. Kuhl, J. Gieseke, S. Schmidt, L. Klotz, T. Klockgether, H.H. Schild, and G.G. Lutterbey Does High-field MR Imaging Have an Influence on the Classification of Patients with Clinically Isolated Syndromes According to Current Diagnostic MR Imaging Criteria for Multiple Sclerosis? AJNR Am. J. Neuroradiol., September 1, 2006; 27(8): 1794 - 1798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. H. Kantarci, L. F. Barcellos, E. J. Atkinson, P. P. Ramsay, R. Lincoln, S. J. Achenbach, M. De Andrade, S. L. Hauser, and B. G. Weinshenker Men transmit MS more often to their children vs women: the Carter effect. Neurology, July 25, 2006; 67(2): 305 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J K Swanton, K Fernando, C M Dalton, K A Miszkiel, A J Thompson, G T Plant, and D H Miller Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes J. Neurol. Neurosurg. Psychiatry, July 1, 2006; 77(7): 830 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fraser, A. Klistorner, S. Graham, R. Garrick, F. Billson, and J. Grigg Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis. Arch Neurol, June 1, 2006; 63(6): 847 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Inglese Multiple sclerosis: new insights and trends. AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 954 - 957. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Whiting, R. Harbord, C. Main, J. J Deeks, G. Filippini, M. Egger, and J. A C Sterne Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review BMJ, April 15, 2006; 332(7546): 875 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Frohman, E. Havrdova, F. Lublin, F. Barkhof, A. Achiron, M. K. Sharief, O. Stuve, M. K. Racke, L. Steinman, H. Weiner, et al. Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis. Arch Neurol, April 1, 2006; 63(4): 614 - 619. [Full Text] [PDF]
|
|
|
|
|
|
J. Masjuan, J. C. Alvarez-Cermeno, N. Garcia-Barragan, M. Diaz-Sanchez, M. Espino, M. C. Sadaba, P. Gonzalez-Porque, J. M. San Millan, and L. M. Villar Clinically isolated syndromes: A new oligoclonal band test accurately predicts conversion to MS Neurology, February 28, 2006; 66(4): 576 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.H. Simon, D. Li, A. Traboulsee, P.K. Coyle, D.L. Arnold, F. Barkhof, J.A. Frank, R. Grossman, D.W. Paty, E.W. Radue, et al. Standardized MR Imaging Protocol for Multiple Sclerosis: Consortium of MS Centers Consensus Guidelines. AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 455 - 461. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Marrie, G. Cutter, T. Tyry, O. Hadjimichael, D. Campagnolo, and T. Vollmer Changes in the ascertainment of multiple sclerosis Neurology, October 11, 2005; 65(7): 1066 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Carmosino, K. M. Brousseau, D. B. Arciniegas, and J. R. Corboy Initial Evaluations for Multiple Sclerosis in a University Multiple Sclerosis Center: Outcomes and Role of Magnetic Resonance Imaging in Referral Arch Neurol, April 1, 2005; 62(4): 585 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H Polman, J. S Wolinsky, and S. C Reingold Multiple sclerosis diagnostic criteria: three years later Multiple Sclerosis, February 1, 2005; 11(1): 5 - 12. [Abstract] [PDF]
|
|
|
|
|
|
B. M. J. Uitdehaag, J. J. G. Geurts, F. Barkhof, C. H. Polman, D. S. Goodin, and E. M. Frohman The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee Neurology, September 28, 2004; 63(6): 1140 - 1140. [Full Text] [PDF]
|
|
|
|
|
|
C. D. Hahn, M. M. Shroff, S. I. Blaser, and B. L. Banwell MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort Neurology, March 9, 2004; 62(5): 806 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C.J. Bot, F. Barkhof, C. H. Polman, G.J. L. a Nijeholt, V. de Groot, E. Bergers, H. J. Ader, and J. A. Castelijns Spinal cord abnormalities in recently diagnosed MS patients: Added value of spinal MRI examination Neurology, January 27, 2004; 62(2): 226 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V Zipoli, E Portaccio, G Siracusa, G Pracucci, S Sorbi, and M P Amato Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosis Multiple Sclerosis, October 1, 2003; 9(5): 481 - 485. [Abstract] [PDF]
|
|
|
|
|
|
J. H. Simon and A. J. Thompson Is multiple sclerosis still a clinical diagnosis? Neurology, September 9, 2003; 61(5): 596 - 597. [Full Text] [PDF]
|
|
|
|
|
|
E. M. Frohman, D. S. Goodin, P. A. Calabresi, J. R. Corboy, P. K. Coyle, M. Filippi, J. A. Frank, S. L. Galetta, R. I. Grossman, K. Hawker, et al. The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology, September 9, 2003; 61(5): 602 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Villoslada, C. Juste, M. Tintore, V. Llorenc, G. Codina, P. Pozo-Rosich, and X. Montalban The immune response against herpesvirus is more prominent in the early stages of MS Neurology, June 24, 2003; 60(12): 1944 - 1948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Giovannoni and C. T. Bever Jr. Patients with clinically isolated syndromes suggestive of MS: Does MRI allow earlier diagnosis? Neurology, January 14, 2003; 60(1): 6 - 7. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
